Literature DB >> 10099827

E2F-1 has properties of a radiosensitizer and its regulation by cyclin A kinase is required for cell survival of fibrosarcoma cells lacking p53.

M Pruschy1, C Wirbelauer, C Glanzmann, S Bodis, W Krek.   

Abstract

Negative regulation of E2F-1 DNA binding function by cyclin A kinase represents part of an S-phase checkpoint control system that, when activated, leads to apoptosis. In this study, we examined the cellular sensitivity and resistance of isogenic mouse fibrosarcoma cell lines, differing primarily in their p53 status, to ectopic expression of wild-type (wt) E2F-1 and cyclin A kinase binding-defective mutants of it. We found that E2F-1 (wt) potently affected the survival of p53+/+ tumor cells but not that of p53-/- cells. In contrast, expression of cyclin A kinase binding-defective E2F-1 species interfered with cell survival of fibrosarcoma cells irrespective of their p53 status. Finally, expression of E2F-1 (wt) in p53-/- fibrosarcoma cells enhanced the cytotoxic effect of ionizing radiation in vitro and in vivo in a mouse tumor model. These results suggest that E2F-1-dependent activation of an S-phase checkpoint is p53 independent and that E2F-1 possesses radiosensitizing properties in the absence of p53.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10099827

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  8 in total

1.  Adenoviral-E2F-1 radiosensitizes p53wild-type and p53null human prostate cancer cells.

Authors:  Khanh H Nguyen; Paul Hachem; Li-Yan Khor; Naji Salem; Kelly K Hunt; Peter R Calkins; Alan Pollack
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-09-01       Impact factor: 7.038

2.  Regulation of E2F1-induced apoptosis by the nucleolar protein RRP1B.

Authors:  Jason C Paik; Bing Wang; Kang Liu; Jerry K Lue; Weei-Chin Lin
Journal:  J Biol Chem       Date:  2009-12-29       Impact factor: 5.157

3.  Cyclin A-CDK phosphorylates Sp1 and enhances Sp1-mediated transcription.

Authors:  P Fojas de Borja; N K Collins; P Du; J Azizkhan-Clifford; M Mudryj
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

4.  Checkpoint Kinase 1 Inhibition Enhances Cisplatin Cytotoxicity and Overcomes Cisplatin Resistance in SCLC by Promoting Mitotic Cell Death.

Authors:  Wei-Hsun Hsu; Xiaoliang Zhao; Jianquan Zhu; In-Kyu Kim; Guanhua Rao; Justine McCutcheon; Shuo-Tse Hsu; Beverly Teicher; Bhaskar Kallakury; Afshin Dowlati; Yu-Wen Zhang; Giuseppe Giaccone
Journal:  J Thorac Oncol       Date:  2019-02-14       Impact factor: 15.609

5.  Adenovirus E2F1 overexpression sensitizes LNCaP and PC3 prostate tumor cells to radiation in vivo.

Authors:  Thirupandiyur S Udayakumar; Radka Stoyanova; Paul Hachem; Mansoor M Ahmed; Alan Pollack
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-02-01       Impact factor: 7.038

6.  Antisense MDM2 enhances E2F1-induced apoptosis and the combination sensitizes androgen-sensitive [corrected] and androgen-insensitive [corrected] prostate cancer cells to radiation.

Authors:  Thirupandiyur S Udayakumar; Paul Hachem; Mansoor M Ahmed; Sudhir Agrawal; Alan Pollack
Journal:  Mol Cancer Res       Date:  2008-11       Impact factor: 5.852

7.  Recombinant mistletoe lectin induces p53-independent apoptosis in tumour cells and cooperates with ionising radiation.

Authors:  K Hostanska; V Vuong; S Rocha; M S Soengas; C Glanzmann; R Saller; S Bodis; M Pruschy
Journal:  Br J Cancer       Date:  2003-06-02       Impact factor: 7.640

Review 8.  E2F1 death pathways as targets for cancer therapy.

Authors:  B M Pützer
Journal:  J Cell Mol Med       Date:  2007 Mar-Apr       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.